The efficacy and safety of DOACs versus LMWH for cancer-associated thrombosis: A systematic review and meta-analysis

Eur J Haematol. 2020 Sep;105(3):360-362. doi: 10.1111/ejh.13453. Epub 2020 Jun 18.
No abstract available

Keywords: DOAC; LMWH; cancer; thrombosis.

Publication types

  • Letter
  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Disease Management
  • Disease Susceptibility
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Neoplasms / complications*
  • Thrombosis / drug therapy*
  • Thrombosis / etiology*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight